​

Funding Round

Series C - CANbridge Pharmaceuticals

Series C - CANbridge Pharmaceuticals

Investment Firm

Overview

CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .

Announced Date

Aug 01, 2018

Funding Type

Series C

Highlights

Location

Asia

Social

Investor Lead

Qiming Venture Partners

Qiming Venture Partners

Qiming Venture Partners is a early_stage_venture and late_stage_venture and private_equity and seed firm.

Participant Investors

1

Investor Name
Participant InvestorQiming Venture Partners

Round Details and Background

CANbridge Pharmaceuticals raised $38100000 on 2018-08-01 in Series C

CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 01, 2020
Series E - CANbridge Pharmaceuticals
11-43.0M
May 23, 2017
Series B - CANbridge Pharmaceuticals
7-25.0M
Oct 27, 2015
Series A - CANbridge Pharmaceuticals
1-10.0M
Dec 02, 2014
Series A - CANbridge Pharmaceuticals
2-10.0M

Recent Activity

There is no recent news or activity for this profile.